Literature DB >> 16436892

Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels.

Nicholas M Selby1, Richard J Fluck, Maarten W Taal, Christopher W McIntyre.   

Abstract

Using acetate as a buffer during hemodialysis is recognized to predispose to intradialytic hypotension; however, bicarbonate-based dialysis is not acetate free. Paired hemodiafiltration (PHF) is a novel online acetate-free technique. We investigated whether PHF is capable of abrogating the changes in systemic hemodynamics and troponin T (cTnT) seen with conventional hemodialysis. Twelve patients entered a randomized crossover study. Blood pressure (BP) and a full range of hemodynamic variables were measured throughout PHF and standard dialysis using continuous pulse wave analysis. We also measured predialysis cTnT in 54 stable and unstable dialysis patients. BP was lower during PHF but without increased instability. Stoke volume and cardiac output declined progressively during both treatments but to a much lesser extent during PHF (p = 0.003, p < 0.0001 respectively), whereas peripheral resistance rose to a larger degree during hemodialysis (p < 0.0001). cTnT levels were lower before PHF as compared with hemodialysis (p = 0.023), with levels falling after PHF and rising after hemodialysis (p < 0.0001). In the supplementary patient group, predialysis median serum cTnT was higher in the unstable patients (p = 0.0001). This study demonstrates that PHF (without exposure to acetate) is associated with less deterioration in systemic hemodynamics, maintenance of BP, and less suppression of myocardial contractility as compared with bicarbonate dialysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436892     DOI: 10.1097/01.mat.0000189725.93808.58

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  8 in total

Review 1.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

2.  Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients.

Authors:  Tobias Breidthardt; James O Burton; Aghogho Odudu; Mohamed Tarek Eldehni; Helen J Jefferies; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

3.  Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.

Authors:  Solmaz Assa; Yoran M Hummel; Adriaan A Voors; Johanna Kuipers; Ralf Westerhuis; Paul E de Jong; Casper F M Franssen
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

Review 4.  Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-11       Impact factor: 2.894

5.  Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.

Authors:  Paul G Davies; Balasubramanian Venkatesh; Thomas J Morgan; Jeffrey J Presneill; Peter S Kruger; Bronwyn J Thomas; Michael S Roberts; Julie Mundy
Journal:  Crit Care       Date:  2011-01-14       Impact factor: 9.097

6.  Plasma-Lyte 148: A clinical review.

Authors:  Laurence Weinberg; Neil Collins; Kiara Van Mourik; Chong Tan; Rinaldo Bellomo
Journal:  World J Crit Care Med       Date:  2016-11-04

7.  Modulation of early inflammatory response by different balanced and non-balanced colloids and crystalloids in a rodent model of endotoxemia.

Authors:  Stefanie Voigtsberger; Martin Urner; Melanie Hasler; Birgit Roth Z'Graggen; Christa Booy; Donat R Spahn; Beatrice Beck-Schimmer
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

8.  Ultrafiltration-profiled hemodialysis to reduce dialysis-related cardiovascular stress: Study protocol for a randomized controlled trial.

Authors:  Matthew J Tugman; Julia H Narendra; Quefeng Li; Yueting Wang; Alan L Hinderliter; Steven M Brunelli; Jennifer E Flythe
Journal:  Contemp Clin Trials Commun       Date:  2019-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.